Moreover, SMURF2 is overexpressed in some types of ovarian cancers and breast cancers4, and high expression levels of SMURF2 are related to poor prognosis in esophageal carcinomas40, suggesting that SMURF2 acts as a tumor promoter in certain tumors. Here, SMURF2 is linked to ovarian carcinoma.